Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder

Stephen T Schultz1, Georgianna G Gould1

  • 1Department of Physiology, School of Medicine, University of Texas Health Science Center San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA.

Autism-Open Access
|October 4, 2016
PubMed

Insights

Acetaminophen use in early childhood is linked to Autism Spectrum Disorder (ASD). This study suggests a reversed association in older children and explores potential endocannabinoid system links, recommending safety reviews for acetaminophen.

Area of Science:

  • Neurodevelopmental disorders
  • Pediatric pharmacology
  • Endocannabinoid system research

Background:

  • Autism Spectrum Disorder (ASD) presents with social communication deficits and restricted behaviors.
  • Previous research indicated a link between early acetaminophen use and increased ASD likelihood.
  • This study investigates the association in older children and explores underlying mechanisms.

Purpose of the Study:

  • To re-examine the association between acetaminophen use and ASD in older children.
  • To investigate the shift in medication preference (acetaminophen vs. ibuprofen) in children with ASD.
  • To explore the potential role of the endocannabinoid system in observed associations.

Main Methods:

  • Case-control study comparing children with and without ASD.
  • Analysis of medication use patterns, including acetaminophen and ibuprofen.
  • Examination of sociability changes during fever in relation to medication use.

Main Results:

  • Acetaminophen use showed a reversed association with ASD in older children compared to younger ones.
  • Children with ASD were more likely to switch from acetaminophen to ibuprofen for fever management.
  • Children with ASD exhibited increased sociability during fevers, potentially linked to endocannabinoid system activation.

Conclusions:

  • Acetaminophen use in early life may be associated with altered endocannabinoid system function in ASD.
  • The findings suggest a need for further investigation into the safety of acetaminophen in pediatric populations.
  • Understanding these associations may inform future research and clinical recommendations regarding medication use in children at risk for ASD.

Related Concept Videos

Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.5K
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.6K
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
677
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349